Sanofi deepens cancer drive with $1.2 billion of deals, Innate jumps – Reuters


Reuters

Sanofi deepens cancer drive with $1.2 billion of deals, Innate jumps
Reuters
Under the new deal with Innate Pharma, worth up to 400 million euros ($436 million) to the Marseilles-based biotech group, Sanofi will get access to new technology to develop so-called bispecific antibodies to fight cancer. The hope is that the new
Sanofi Inks Multiple Deals, Sarilumab under FDA ReviewZacks.com
European drug giants sign agreements with Cambridge firmsThe Boston Globe
Warp Drive, Surface, Bamboo Cut Deals on Eve of JP MorganXconomy
Financial Times
all 63 news articles »

Read More…

Share This: